Scientific Reports (Nov 2023)
Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine
Abstract
No abstracts available.
Scientific Reports (Nov 2023)